
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc.(HALO)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · HALO · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
75
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Halozyme Therapeutics, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
HALO 季度内部人买卖趋势
HALO 内幕交易卖出 · HALO 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · HALO CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HALO 高管卖出股份 · HALO 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | Torley Helen PRESIDENT AND CEO · Director | Option | 20,000 | $241K | Form 4 |
| Jun 1, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 1,610 | $107K | Form 4 |
| Jun 3, 2026 | Torley Helen PRESIDENT AND CEO · Director | Option | 10,000 | $121K | Form 4 |
| Jun 3, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 400 | $27K | Form 4 |
| Jun 3, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 1,500 | $102K | Form 4 |
| Jun 3, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 2,000 | $137K | Form 4 |
| Jun 1, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 12,989 | $876K | Form 4 |
| Jun 2, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 16,600 | $1.10M⚡ | Form 4 |
| Jun 2, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 3,400 | $227K | Form 4 |
| Jun 1, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 5,401 | $369K | Form 4 |
| Jun 3, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 6,100 | $425K | Form 4 |
| Jun 1, 2026 | Connaughton Bernadette Director | Sale | 1,625 | $108K | Form 4 |
| May 12, 2026 | Torley Helen PRESIDENT AND CEO · Director | Option | 20,000 | $241K | Form 4 |
| May 12, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 100 | $7K | Form 4 |
| May 12, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 1,398 | $98K | Form 4 |
| May 11, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 9,725 | $629K | Form 4 |
| May 13, 2026 | Torley Helen PRESIDENT AND CEO · Director | Option | 10,000 | $121K | Form 4 |
| May 12, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 9,802 | $700K | Form 4 |
| May 13, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 2,100 | $143K | Form 4 |
| May 11, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 3,575 | $234K | Form 4 |
| May 13, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 3,350 | $231K | Form 4 |
| May 12, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 5,900 | $426K | Form 4 |
| May 13, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 3,950 | $276K | Form 4 |
| May 11, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 6,700 | $444K | Form 4 |
| May 12, 2026 | Torley Helen PRESIDENT AND CEO · Director | Sale | 2,800 | $205K | Form 4 |
Torley Helen
PRESIDENT AND CEO · Director
日期
Jun 2
股数
16,600
均价
$66.31
总金额
$1.10M ⚡
Torley Helen
PRESIDENT AND CEO · Director
日期
May 12
股数
20,000
均价
$12.07
总金额
$241K
Torley Helen
PRESIDENT AND CEO · Director
日期
May 13
股数
10,000
均价
$12.07
总金额
$121K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HALO 内幕交易
HALO 内幕交易
Halozyme Therapeutics, Inc.(HALO)内幕交易数据来源于公司内部人(包括Torley Helen (PRESIDENT AND CEO · Director), Caudill Cortney (SVP, CHIEF OPERATING OFFICER), Snyder Mark Howard (SVP, CHIEF LEGAL OFFICER))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。HALO内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Halozyme Therapeutics, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
HALO 内幕交易 · 5个问题Halozyme Therapeutics, Inc.(HALO)的内部人包括高管和董事,如Torley Helen (PRESIDENT AND CEO · Director), Caudill Cortney (SVP, CHIEF OPERATING OFFICER), Snyder Mark Howard (SVP, CHIEF LEGAL OFFICER)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026